These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer. Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761 [TBL] [Abstract][Full Text] [Related]
4. Functional interdependence of BRD4 and DOT1L in MLL leukemia. Gilan O; Lam EY; Becher I; Lugo D; Cannizzaro E; Joberty G; Ward A; Wiese M; Fong CY; Ftouni S; Tyler D; Stanley K; MacPherson L; Weng CF; Chan YC; Ghisi M; Smil D; Carpenter C; Brown P; Garton N; Blewitt ME; Bannister AJ; Kouzarides T; Huntly BJ; Johnstone RW; Drewes G; Dawson SJ; Arrowsmith CH; Grandi P; Prinjha RK; Dawson MA Nat Struct Mol Biol; 2016 Jul; 23(7):673-81. PubMed ID: 27294782 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor. FitzGerald J; Moureau S; Drogaris P; O'Connell E; Abshiru N; Verreault A; Thibault P; Grenon M; Lowndes NF PLoS One; 2011 Feb; 6(2):e14714. PubMed ID: 21383990 [TBL] [Abstract][Full Text] [Related]
7. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis. Mahmoudi T; Boj SF; Hatzis P; Li VS; Taouatas N; Vries RG; Teunissen H; Begthel H; Korving J; Mohammed S; Heck AJ; Clevers H PLoS Biol; 2010 Nov; 8(11):e1000539. PubMed ID: 21103407 [TBL] [Abstract][Full Text] [Related]
8. DOT1L-mediated H3K79 methylation in chromatin is dispensable for Wnt pathway-specific and other intestinal epithelial functions. Ho LL; Sinha A; Verzi M; Bernt KM; Armstrong SA; Shivdasani RA Mol Cell Biol; 2013 May; 33(9):1735-45. PubMed ID: 23428873 [TBL] [Abstract][Full Text] [Related]
9. Differential Methylation of H3K79 Reveals DOT1L Target Genes and Function in the Cerebellum In Vivo. Bovio PP; Franz H; Heidrich S; Rauleac T; Kilpert F; Manke T; Vogel T Mol Neurobiol; 2019 Jun; 56(6):4273-4287. PubMed ID: 30302725 [TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of the histone lysine 79 methyltransferase Dot1L in nephron progenitors causes congenital renal dysplasia. Wang F; Ngo J; Li Y; Liu H; Chen CH; Saifudeen Z; Sequeira-Lopez MLS; El-Dahr SS Epigenetics; 2021 Nov; 16(11):1235-1250. PubMed ID: 33315499 [TBL] [Abstract][Full Text] [Related]
11. Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. Salvati A; Melone V; Sellitto A; Rizzo F; Tarallo R; Nyman TA; Giurato G; Nassa G; Weisz A Breast Cancer Res; 2022 Jul; 24(1):52. PubMed ID: 35850772 [TBL] [Abstract][Full Text] [Related]
12. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins. Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074 [TBL] [Abstract][Full Text] [Related]
13. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation. Aslam MA; Alemdehy MF; Kwesi-Maliepaard EM; Muhaimin FI; Caganova M; Pardieck IN; van den Brand T; van Welsem T; de Rink I; Song JY; de Wit E; Arens R; Jacobs H; van Leeuwen F EMBO Rep; 2021 Feb; 22(2):e51184. PubMed ID: 33410591 [TBL] [Abstract][Full Text] [Related]
14. The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases. Tao M; Shi Y; Chen H; Li J; Wang Y; Ma X; Du L; Wang Y; Yang X; Hu Y; Zhou X; Zhong Q; Yan D; Qiu A; Zhuang S; Liu N Mol Biomed; 2024 Jan; 5(1):3. PubMed ID: 38172378 [TBL] [Abstract][Full Text] [Related]
15. The Methyltransferase DOT1L Controls Activation and Lineage Integrity in CD4 Scheer S; Runting J; Bramhall M; Russ B; Zaini A; Ellemor J; Rodrigues G; Ng J; Zaph C Cell Rep; 2020 Dec; 33(11):108505. PubMed ID: 33326781 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional activator DOT1L putatively regulates human embryonic stem cell differentiation into the cardiac lineage. Pursani V; Bhartiya D; Tanavde V; Bashir M; Sampath P Stem Cell Res Ther; 2018 Apr; 9(1):97. PubMed ID: 29631608 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the DOT1L network: implications of diverse roles for DOT1L. Park G; Gong Z; Chen J; Kim JE Protein J; 2010 Apr; 29(3):213-23. PubMed ID: 20431927 [TBL] [Abstract][Full Text] [Related]
19. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy. Mao Y; Sun Y; Wu Z; Zheng J; Zhang J; Zeng J; Lee C; Kim JK Cell Death Dis; 2021 Dec; 12(12):1141. PubMed ID: 34887387 [TBL] [Abstract][Full Text] [Related]
20. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness. Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]